Metaraminol Bitartrate: Product Information and Physical Properties

What is Metaraminol Bitartrate?

Metaraminol bitartrate is a crystalline solid with a well-established profile in both clinical and research settings. The compound comes from the combination of metaraminol, a synthetic amine, and bitartrate, forming a salt that aids with stability and solubility. Once you start handling it, the characteristics stand out: it usually takes the form of white to off-white powder or flakes, sometimes even described as small pearls under certain manufacturing processes. The HS Code for metaraminol bitartrate is 2922199090, reflecting its category among pharmaceutical raw materials and chemicals. It holds a key place as both an active agent and as a useful reference material in laboratory environments.

Chemical Structure and Molecular Properties

The molecular formula for metaraminol bitartrate is C9H13NO2·C4H6O6, and its structure involves the parent phenylethanolamine group connected through ionic interaction with the bitartrate component. When you look up the structure in a chemistry text, you see three main elements anchoring the molecule: the aromatic ring, the side-chain containing a hydroxyl group, and the tartrate moiety coming from tartaric acid. This combination shapes not only the compound’s behavior in solution but also its storage needs. Its molecular weight typically clocks in at about 307.3 g/mol, and this plays into the stoichiometry of whatever role it takes in the lab. The melting point often sits between 187°C and 193°C, a handy feature that signals the beginning of any decomposition during heat exposure.

Physical Properties and Specifications

Metaraminol bitartrate comes in various physical forms, but the most straightforward example is a tightly packed powder. Sometimes you see it as fine flakes, especially if stored in high humidity; occasionally, you also come across small, lustrous crystals. Its density is around 1.485 g/cm³ at room temperature. In crystal or powder form, the material dissolves well in water and forms a clear solution, which helps those working in labs or hospital pharmacies. If you pour a few grams into a beaker and add distilled water, the powder dissolves smoothly with mild stirring, creating a stable aqueous solution. The solution, clear and colorless, makes calculations for infusions straightforward. For practitioners, those characteristics mean you don’t waste time worrying about undissolved particles or inaccurate dosing.

Safety, Handling, and Hazard Characteristics

Concerns over safety can’t be brushed aside. Metaraminol bitartrate isn’t the most hazardous compound, but solid chemical common sense stays important. Dust can cause short-term irritation to the skin, eyes, and upper airways. Prolonged exposure may bring mild systemic symptoms. In solution, the risk mainly stems from accidental spills or ingestion. Essentials in any handling scenario should include gloves, goggles, and decent ventilation—lab basics that keep people safe. Material Safety Data Sheets typically mark this compound as slightly hazardous in case of contact or inhalation, but not acutely toxic. Accidents rarely lead to long-term harm, provided spills or exposures receive prompt rinsing with water and contaminated clothing gets removed.

Applications and Role as a Chemical Raw Material

Metaraminol bitartrate isn’t only about medical emergencies; it fits across several domains of chemistry and pharmaceutical development. As a raw material, its stable crystalline structure makes it a go-to reference compound during synthesis validation and purity verification. Hospitals and clinics most often rely on prepared solutions for vascular support, but researchers dig deeper into its mechanism and metabolic fate, using the raw solid as a control standard. Laboratories benefit from its readiness to dissolve and crystal clarity, assuring consistent experiments and easier solution preparations. Supply chains appreciate its stable shelf life and reliable density, which cuts the guesswork from inventory control and formulation processes.

Potential Hazards and Regulatory Status

Every batch of metaraminol bitartrate carries regulatory oversight. The HS Code not only flags its trade status but ties right into customs and regulatory screening worldwide. Because it can produce potent cardiovascular effects, it falls under controlled handling rules, even as a raw material. Lax storage can lead to moisture absorption and slow product breakdown, so sealed containers and dry storage keep it usable over long stretches. Shipping labels mark it as a substance requiring careful handling, yet it rarely draws the more severe hazard pictograms reserved for acutely toxic reagents or caustic acids. The risks, while present, remain manageable for anybody who follows standard chemical hygiene rules.

Improving Safety and Quality in Handling and Use

Practice across institutions varies, but people can always lift standards by paying attention to packaging, batch integrity, and robust training. Avoiding cross-contamination starts with clean tools and labeled containers. Storage protocols benefit from using desiccants and avoiding high temperatures or sunlight, since breakdown products can lower product effectiveness and reliability. Regular audits of stock and staff routines help spot issues before they result in error or waste. Training remains a strong shield against accidents, since new staff—both in hospital and lab settings—often underestimate the risks from solids compared to liquids or gases. Regulatory authorities can help by ensuring clear documentation, up-to-date hazard labels, and support materials that emphasize practical precautions over vague warnings.

Responsible Use and Societal Impact

Even though metaraminol bitartrate lands at the intersection of chemistry and medicine, the broader world interacts with it only through well-developed supply chains and product labeling. Patients and professionals trust that what arrives at their doorstep meets established standards for identity, purity, and potency. A single breakdown—be it temperature abuse that causes crystal clumping, or improper labeling—can pose risks to those relying on the compound. The role of chemical manufacturers, distributors, and regulatory agencies becomes more than just box-checking. It’s about building trust in a substance whose benefits exist because the system as a whole supports careful manufacture, disciplined handling, and transparent communication from synthesis all the way to end use.